Fig. 2From: Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study)Data collection timeline (SPIRIT figure). HFS, hand-foot syndrome; PRO, patient-reported outcome; Cox-2, cycloxygenase-2Back to article page